Glenmede Trust’s AngioDynamics ANGO Stock Holding History

Glenmede Trust’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,256	Closed	-$15K	–	1250
2020 Q3	$15K	Buy	1,256 +65	+5%	+$617	﹤0.01%	1708
2020 Q2	$12K	Buy	1,191 +644	+118%	+$6.64K	﹤0.01%	1788
2020 Q1	$8K	Hold	547	–	–	﹤0.01%	2502
2019 Q4	$8K	Sell	547 -410	-43%	-$6.26K	﹤0.01%	2502
2019 Q3	$17	Buy	957 +452	+90%	+$8.84K	﹤0.01%	2114
2019 Q2	$9	Sell	505 -19	-4%	-$387	﹤0.01%	2402
2019 Q1	$11	Sell	524 -74	-12%	-$1.61K	﹤0.01%	2315
2018 Q4	$12	Sell	598 -334	-36%	-$6.91K	﹤0.01%	2194
2018 Q3	$20K	Buy	932 +434	+87%	+$9.64K	﹤0.01%	1356
2018 Q2	$11K	Sell	498 -4	-0.8%	-$82	﹤0.01%	1866
2018 Q1	$7K	Hold	502	–	–	﹤0.01%	2288
2017 Q4	$7K	Buy	502 +298	+146%	+$5.08K	﹤0.01%	2288
2017 Q3	$3K	Hold	204	–	–	﹤0.01%	2462
2017 Q2	$3K	Hold	204	–	–	﹤0.01%	2385
2017 Q1	$3K	Buy	+204	New	+$3.41K	﹤0.01%	2385

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Glenmede Trust's ANGO Position: Q4 2020 in Review

Glenmede Trust sold out of AngioDynamics (ANGO) in Q4 2020, closing a stake of 1,256 shares — an estimated $15K sold.

Glenmede Trust first reported a position in ANGO in Q1 2017 and held it in 15 quarters. The position peaked at $20K in Q3 2018. 147 funds tracked by Wall St. Rank hold ANGO as of Q4 2020.

Glenmede Trust reported no remaining AngioDynamics position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 1,256 AngioDynamics shares in Q4 2020, an estimated $15K.
Glenmede Trust first reported a position in AngioDynamics in Q1 2017 and held it in 15 quarters.
Glenmede Trust's AngioDynamics position peaked at $20K in Q3 2018.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.